Although defibrillators are sometimes touted as “high-energy” devices, the term “energy” actually refers to the electric current that shocks the heart into rhythm. ZOLL® defibrillators use low-energy, high-current RBW, a waveform that provides more current than any other biphasic waveform on the market. In fact, the United States Food and Drug Administration (FDA) has approved our RBW as the only waveform to claim superiority over monophasic waveforms.

The high-current capabilities offered in our defibrillators are particularly important for your high-impedance, difficult-to-defibrillate patients. Our biphasic defibrillators bring you and your patients multiple benefits: These devices are smaller and lighter while mitigating skin burns and injury to the heart. You can trust ZOLL technology as it has undergone extensive studies with testing on more than 7,000 patients.1

1 “The Heart of the Matter: What really defibrillates the heart?” ZOLL White Paper, 2015.

Innovative cardiac care

You put your patients at the heart of everything you do. At ZOLL, we do, too. You can rely on our suite of solutions for cardiac care from pre-hospital to post-discharge and everything in between. You have access to a full range of products designed to help protect your patients who have experienced a cardiac event.

Learn more

Helpful resources

ACLS/PALS defibrillation protocols with the ZOLL Rectilinear Biphasic waveform

Understand how the American Heart Association (AHA) defibrillation protocols apply to ZOLL’s Rectilinear Biphasic waveform.

Learn More

The Heart of the Matter

ZOLL defibrillators with RBW provide more current than the high-energy biphasic waveforms used by others. This capability is particularly important for the difficult-to-defibrillate, high-impedance patient.

Read More